T
Tafalgie Therapeutics
Raised $14.1M in a Series A round, announced 15 September 2025.
Round
$14.1MSeries A, 15 September 2025
Funds the Phase 2A trial of lead candidate TT5 and two further pain candidates.
- Amount
- $14.1M
- Stage
- Series A
- Announced
- 15 September 2025
- Lead
- family offices
- Other investors
- business angels, existing investors
- Use of funds
- Funds the Phase 2A trial of lead candidate TT5 and two further pain candidates.
- Checked
- Amount and date checked against the press source
- Source
- Tafalgie Therapeutics raises 12M euros Series A mypharma-editions.com
Company
Develops non-opioid pain drugs from TAFA4-derived peptides
- Based in
- Marseille, 🇫🇷France
- Sector
- Health
- Website
- tafalgie.fr ↗
Questions
How much has Tafalgie Therapeutics raised?
Tafalgie Therapeutics raised $14.1M in a Series A round, announced on 15 September 2025.
Who invested in Tafalgie Therapeutics?
family offices led. Investors include family offices, business angels and existing investors.
